FDG-PET in the Diagnosis of Autoimmune Encephalitis
Recruiting now
Conditions studied: Autoimmune Encephalitis
In brief
The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients with Alzheimer's disease (AD). The main question it aims to answer is: •is there a specific pattern of brain metabolism in patients with autoimmune encephalitis Participants data and images will be retrospectively collected from hospital records, and FDG-PET images will be analyzed by means of statistical parametric mapping (SPM). Controls will be selected from validated public databases.
Key facts
- Study ID
- NCT06019975
- Run by
- University of Milano Bicocca
- People needed
- 90
- Starts
- 2023-03-01
- Expected to finish
- 2027-04-30
- Last updated by the study team
- 2026-03-24
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of autoimmune encephalitis according to clinical criteria
- Brain magnetic resonance imaging performed between clinical presentation and treatment
- Cerebrospinal fluid analysis performed between clinical presentation and treatment
- Brain FDG-PET performed between clinical presentation and treatment
- Autoantibodies testing performed between clinical presentation and treatment
You may not qualify if…
- Refusal to give consent for the study
Where it is running
- Fondazione IRCCS Mondino — Pavia, Lombardy, Italy (enrolling)
- Fondazione IRCCS San Gerardo dei Tintori — Monza, Monza e Della Brianza, Italy (enrolling)
- Azienda Sanitaria Universitaria Friuli Centrale — Udine, Friuli Venezia Giulia, Italy
- IRCCS Ospedale Policlinico San Martino — Genoa, Liguria, Italy
- Fondazione IRCCS Istituto Neurologico "Carlo Besta" — Milan, Milano, Italy
- Ospedale San Paolo — Milan, Milano, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.